CSTL · Company research
Castle Biosciences, Inc. Common Stock (CSTL): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 33 | $1,069,740,810 | 1007624810.00 | 55.5161290322580645 | — | — | 10.3310684140382052 | 2.2758990064463970 | 163.29427720958632270221 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.